Allergen, Individual-Weed pollen Saltwort / Russian Thistle (Salsola kali / pestifer) Serum W11

The Allergen, Individual-Weed pollen Saltwort / Russian Thistle (Salsola kali / pestifer) Serum W11 is a laboratory serum test that measures specific IgE antibodies to Saltwort pollen in the blood. Using a quantitative immunoassay on a venous serum sample, the test detects and reports the level of sensitization to Salsola kali, providing objective evidence of allergic response to this common desert weed.

This test is important for diagnosing seasonal allergic rhinitis, conjunctivitis, or pollen‑triggered asthma where Saltwort exposure is suspected — a relevant concern in the UAE’s arid and semi‑arid environments. Results help clinicians confirm sensitization, tailor environmental avoidance advice, select appropriate pharmacotherapy, and determine eligibility or targets for allergen immunotherapy. Home phlebotomy and sample pickup are available across Dubai and the UAE for convenient testing and follow-up with your healthcare provider.

• Salsola kali (Saltwort / Russian Thistle) specific IgE (kU/L)
• Quantitative specific IgE level
• IgE sensitization class / interpretation

• Recurrent seasonal sneezing, nasal congestion or itchy/watery eyes during pollen seasons
• Worsening or seasonal asthma symptoms linked to outdoor exposure
• Suspected pollen allergy not explained by other allergen tests
• Before initiating allergen-specific immunotherapy targeting weed pollens
• Occupational or frequent outdoor exposure to desert weeds (e.g., landscaping, construction)

• Accurate identification of sensitization to Saltwort (Salsola kali)
• Quantitative results to guide clinical interpretation and treatment planning
• Supports selection and monitoring of allergen immunotherapy when indicated
• Safe alternative or complement to skin testing when contraindicated
• Home sample collection and lab-standard reporting across Dubai and the UAE

• Venous blood sample (serum) collected by trained phlebotomist — typically 3–5 mL
• No fasting required; maintain usual hydration and medications unless instructed otherwise
• Inform the clinician or phlebotomist if receiving anti‑IgE therapy (e.g., omalizumab), recent systemic immunosuppression, or ongoing allergen immunotherapy
• Home collection and same‑lab analysis available across Dubai and the UAE; results provided with laboratory interpretation for clinician review